Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dongni Yi

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Current Oncology (Toronto, Ont.)|November 24, 2022
Treating Multiple Myeloma in the Context of the Bone Marrow MicroenvironmentMatthew Ho, Alexander Xiao, Dongni Yi, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 24, 2024
Chimeric Antigen Receptor T - Cell Therapy for Large B-Cell Lymphoma Patients with Central Nervous System Involvement, a Systematic Review and Meta-analysisGhada Elgohary, Yang Yang, Mia Gergis, et al.
Hematology/Oncology and Stem Cell Therapy|December 20, 2022
Chimeric Antigen Receptor T Cell Therapy For Solid TumorsJingmei Hsu, Yang Yang, Mia Gergis, et al.
Hematology/Oncology and Stem Cell Therapy|December 20, 2022
Allogeneic Chimeric Antigen Receptor T Cells for Hematologic MalignanciesYang Yang, Xia Bi, Mia Gergis, et al.
Hematology/Oncology and Stem Cell Therapy|December 20, 2022
Chimeric Antigen Receptor T-cell Therapy for Acute Myeloid LeukemiaXia Bi, Jingmei Hsu, Mia Gergis, et al.
Hematology/Oncology and Stem Cell Therapy|December 20, 2022
Next-Generation Chimeric Antigen Receptor T-cellsDongni Yi, Mia Gergis, Jingmei Hsu, et al.
Hematology/Oncology and Stem Cell Therapy|December 20, 2022
Chimeric Antigen Receptor T-cell Therapies in Lymphoma Patients with Central Nervous System InvolvementDongni Yi, Mia Gergis, Ghada Elgohary, et al.
American Journal of Cancer Research|July 11, 2022
Dasatinib and interferon alpha synergistically induce pyroptosis-like cell death in philadelphia chromosome positive acute lymphoblastic leukemiaYang Dai, Jingcao Huang, Pu Kuang, et al.
Oncotarget|November 1, 2019
Targeting glutaminase1 and synergizing with clinical drugs achieved more promising antitumor activity on multiple myelomaQiang Qiu, Mengyuan Li, Linyu Yang, et al.
The American Journal of Surgical Pathology|June 15, 2026
Absent Cyclin D1 Expression in Myeloid Sarcomas Distinguishes From Malignant Histiocytic Neoplasms: When Morphologic Ambiguity is DeceptiveAlyssa M Lee, Neha Seth, Wayne Tam, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Current Oncology (Toronto, Ont.)|November 24, 2022
Treating Multiple Myeloma in the Context of the Bone Marrow MicroenvironmentMatthew Ho, Alexander Xiao, Dongni Yi, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 24, 2024
Chimeric Antigen Receptor T - Cell Therapy for Large B-Cell Lymphoma Patients with Central Nervous System Involvement, a Systematic Review and Meta-analysisGhada Elgohary, Yang Yang, Mia Gergis, et al.
Hematology/Oncology and Stem Cell Therapy|December 20, 2022
Chimeric Antigen Receptor T Cell Therapy For Solid TumorsJingmei Hsu, Yang Yang, Mia Gergis, et al.
Hematology/Oncology and Stem Cell Therapy|December 20, 2022
Allogeneic Chimeric Antigen Receptor T Cells for Hematologic MalignanciesYang Yang, Xia Bi, Mia Gergis, et al.
Hematology/Oncology and Stem Cell Therapy|December 20, 2022
Chimeric Antigen Receptor T-cell Therapy for Acute Myeloid LeukemiaXia Bi, Jingmei Hsu, Mia Gergis, et al.
Hematology/Oncology and Stem Cell Therapy|December 20, 2022
Next-Generation Chimeric Antigen Receptor T-cellsDongni Yi, Mia Gergis, Jingmei Hsu, et al.
Hematology/Oncology and Stem Cell Therapy|December 20, 2022
Chimeric Antigen Receptor T-cell Therapies in Lymphoma Patients with Central Nervous System InvolvementDongni Yi, Mia Gergis, Ghada Elgohary, et al.
American Journal of Cancer Research|July 11, 2022
Dasatinib and interferon alpha synergistically induce pyroptosis-like cell death in philadelphia chromosome positive acute lymphoblastic leukemiaYang Dai, Jingcao Huang, Pu Kuang, et al.
Oncotarget|November 1, 2019
Targeting glutaminase1 and synergizing with clinical drugs achieved more promising antitumor activity on multiple myelomaQiang Qiu, Mengyuan Li, Linyu Yang, et al.
The American Journal of Surgical Pathology|June 15, 2026
Absent Cyclin D1 Expression in Myeloid Sarcomas Distinguishes From Malignant Histiocytic Neoplasms: When Morphologic Ambiguity is DeceptiveAlyssa M Lee, Neha Seth, Wayne Tam, et al.
Pageof 2